vTv Therapeutics (VTVT) Return on Sales [ROS] (2014 - 2026)
vTv Therapeutics' Return on Sales [ROS] came in at -25.11% for Q2 2026, up 150692.54 percentage points from -150717.65% a year earlier but down 88.26 percentage points from the prior quarter.
Powered by 
Analysis
vTv Therapeutics (VTVT) Return on Sales [ROS] (2014 - 2026) Analysis & Trends
For FY2024, vTv Therapeutics' Return on Sales [ROS] was -2377.58%.
- Return on Sales [ROS] carries a five-year change of -1621.72 percentage points (FY2019 to FY2024).
- Going back by year, Return on Sales [ROS] was -1116.95% in FY2022 (-576.07 pp), -540.87% in FY2021 (-356.09 pp) and -184.78% in FY2020 (+571.08 pp).
- The five-year range for quarterly Return on Sales [ROS] is -305100.00% (Q2 2023) to 63.15% (Q1 2026).
- Year-over-year, Return on Sales [ROS] increased in three of the last six quarters, with an average year-over-year change of +21506.24 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2024 (a gain of 302814.30 percentage points), and the weakest in Q3 2023 (a drop of 300180.21 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | vTv Therapeutics | 260.90 Mn | -89.97 Mn | - | -29.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -29.80% |
| Jun 30, 2026 | -25.11% |
| Mar 31, 2026 | 63.15% |
| Sep 30, 2025 | -175,382.35% |
| Jun 30, 2025 | -150,717.65% |
| Mar 31, 2025 | -147,388.24% |
| Dec 31, 2024 | -28,776.47% |
| Sep 30, 2024 | -2,399.50% |
| Jun 30, 2024 | -2,285.70% |
| Mar 31, 2024 | -562.70% |
| Sep 30, 2023 | -301,533.33% |
| Jun 30, 2023 | -305,100.00% |
| Mar 31, 2023 | -130,477.78% |
| Dec 31, 2022 | -70,477.78% |
| Sep 30, 2022 | -1,353.12% |
| Jun 30, 2022 | -44,744.44% |
| Mar 31, 2022 | -324.05% |
| Dec 31, 2021 | -123,433.33% |
| Sep 30, 2021 | -53.43% |
| Jun 30, 2021 | -51,888.89% |
API Access
vTv Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VTVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "VTVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VTVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();